Skip to Content Skip to Content

Hannah Messinger Hannah Messinger

Senior Medical Communications Officer, Penn Medicine
  • Hannah.Messinger@uphs.upenn.edu
  • 215-349-5653
  • Articles from Hannah Messinger
    Knockdown and replace: A gene therapy twofer to treat blindness
    Beltran rhodopsin

    Maps reflecting the thickness of a key layer of the retina show how a gene therapy treatment (right panels) protected against severe retinal degeneration.

    Knockdown and replace: A gene therapy twofer to treat blindness

    More than 150 different mutations in the light-sensing molecule rhodopsin can cause retinitis pigmentosa, characterized by a progressive loss of night and peripheral vision, and a team of researchers have developed a treatment for the condition. Successful results in dogs set the stage for testing in humans.